Tag: drug discovery market overview

Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.

Drug Discovery Market Set To Climb From $142.53 Billion In 2026 To $250.5 Billion By 2030

The drug discovery market size has experienced significant expansion in recent years. It will grow from $124.11 billion in 2025 to $142.54 billion in 2026 at a compound annual growth rate (CAGR) of 14.8%. This historical growth can be attributed to several factors, including an increase in chronic and infectious diseases, advancements in molecular biology techniques, heightened R&D spending by pharmaceutical companies, a rise in biotechnology collaborations, and the availability of research funding.

The drug discovery market is poised for significant expansion in the coming years. It is projected to reach a valuation of $250.51 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 15.1%. This expected growth during the forecast period is driven by the emergence of AI-driven drug discovery platforms, the expanding scope of personalized medicine, the integration of omics data into drug design, the increasing outsourcing in the biopharmaceutical sector, and the adoption of automation and robotics in laboratory environments. Prominent trends anticipated in this period include advancements in high-throughput screening, the development of targeted drugs, innovative personalized medicine strategies, the incorporation of pharmacogenomics, and the use of nanotechnology in drug discovery.

Get A Free Sample Report With In-Depth Market Insights:

https://thebusinessresearchcompany.com/sample_request?id=88969109&type=smp&name=Drug%20Discovery%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Drug Discovery Market Growth Catalysts And Demand Drivers

The drug discovery market is anticipated to expand due to increasing healthcare spending. Globally, nations allocate a significant portion of their GDP to healthcare costs, encompassing hospital services, doctor and clinic visits, various professional services, dental treatments, additional health, residential, and personal care, home healthcare, nursing homes, continuing care retirement communities, prescription medicines, and other related expenditures. A substantial component of health expenditure is dedicated to drug discovery, crucial for disease treatment and life extension. The demand for novel drugs to address emerging diseases is growing. As an illustration, data from October 2024 from the Centers for Medicare and Medicaid Services, a US-based federal agency, revealed that national health expenditure increased by 4.1% to $4.5 trillion in 2022, equivalent to $13,493 per person. Furthermore, for the period 2023–32, the average national health expenditure growth (5.6%) is projected to surpass the average GDP growth (4.3%), leading to a rise in healthcare spending as a share of GDP from 17.3 percent in 2022 to 19.7 percent in 2032. Consequently, the expansion of the drug discovery market is being propelled by increasing healthcare expenditures.

Drug Discovery Market Segment Outlook: Which Categories Are Growing Fastest?

The drug discovery market covered in this report is segmented –

1) By Drug Type: Small Molecule, Large Molecule

2) By Process: Target Selection, Target Validation, Hit-To-Lead Identification, Lead Optimization, Candidate Validation

3) By Technology: High Throughput Screening, Spectroscopy, Combinatorial Chemistry, Biochips, Pharmacogenomics And Pharmacogenetics, Bioinformatics, Metabolomics, Nanotechnology, Other Technologies

4) By Therapeutic Area: Oncology, Neurology, Infectious And Immune System Diseases, Digestive System Diseases, Cardiovascular Diseases, Diabetes, Respiratory Disease, Other Therapeutic Areas

5) By End User: Pharmaceutical Companies, CROs, Other End-Users

Subsegments:

1) By Small Molecule: Synthetic Small Molecules, Natural Small Molecules, Targeted Small Molecule Drugs

2) By Large Molecule: Monoclonal Antibodies, Proteins And Peptides, Nucleic Acid-Based Therapies

Drug Discovery Market Trends Shaping Long-Term Demand

Major companies operating in the drug discovery market are actively incorporating various innovative technologies, including artificial intelligence and imaging, to decrease the time necessary for drug development. Imaging technology specifically enables the non-invasive visualization, characterization, and quantification of biological activities occurring within organisms when exposed to medications. These techniques, which capitalize on the strengths of either specialized probes or the tissue itself, are essential for deepening the understanding of diseases and identifying new therapeutic options. For instance, in May 2023, Google Cloud launched two advanced AI-powered platforms, namely the Target and Lead Identification Suite and the Multiomics Suite, to expedite drug discovery and refine precision medicine. These tools are engineered to assist biotechnology and pharmaceutical companies in progressing their efforts in drug discovery and precision medicine. The Target and Lead Identification Suite aids in discerning the function of amino acids and proteins, whereas the Multiomics Suite accelerates the discovery and interpretation of genomic data, thereby contributing to the design of personalized treatments.

Drug Discovery Market Leading Companies And Competitive Benchmarking

Major companies operating in the drug discovery market are Pfizer Inc., Merck & Co. Inc., Novartis International AG, Thermo Fisher Scientific Inc., WuXi AppTec Group, GlaxoSmithKline plc, Eli Lilly and Company, Laboratory Corporation of America Holdings, Evotec SE, Eurofins Scientific SE, Agilent Technologies Inc., Sanofi S.A., Charles River Laboratories International Inc., Pharmaron Ltd., Viva Biotech Ltd., Albany Molecular Research Inc., Schrödinger Inc., BioDuro Ltd., Aptuit LLC, Selvita S.A., Sygnature Discovery Limited, Jubilant Biosys Limited, Gero Limited, Domainex Ltd., Verge Genomics lnc., Aqemia SAS, BenevolentAI Limited, EPIVAX INC., ProteinQure lnc., Synlogic Inc., ChemPartner Co. Ltd., WuXi Biologics lnc., Abzena plc, Lonza Group Ltd., Catalent lnc., Recursion Pharmaceuticals Inc.

View The Full Drug Discovery Market Report:

https://thebusinessresearchcompany.com/report/drug-discovery-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Drug Discovery Market Regional Breakdown: Where Is Demand Concentrated?

North America was the largest region in the drug discovery market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the drug discovery market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.

Drug Discovery Market Value Analysis: What Growth Is Expected Over The Forecast Period?

The drug discovery market has seen a notable surge in scale over recent times. Its value is projected to climb from $124.11 billion in 2025 to $142.54 billion in 2026, reflecting a compound annual growth rate (CAGR) of 14.8%. This historical expansion has been largely driven by a rising incidence of chronic and infectious conditions, progress in molecular biology methods, increased investment in research and development from pharmaceutical firms, heightened partnerships within the biotechnology sector, and accessible research funding.

The market for drug discovery is projected to experience significant expansion in the coming years, with its size anticipated to reach $250.51 billion by 2030, driven by a compound annual growth rate (CAGR) of 15.1%. This growth during the forecast period is fueled by the rise of AI-driven drug discovery platforms, the broadening scope of personalized medicine, the use of omics data in drug design, increased biopharmaceutical outsourcing, and the integration of automation and robotics into laboratory settings. Key trends shaping the forecast period comprise progress in high-throughput screening, the development of targeted therapies, adoption of personalized medicine strategies, incorporation of pharmacogenomics, and drug discovery enabled by nanotechnology.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7746&type=smp&utm_source=BlogsPR&utm_medium=Paid&utm_campaign=Jul_PR

Drug Discovery Market Growth Drivers: What Factors Are Accelerating Expansion?

The drug discovery market is anticipated to be driven forward by increasing healthcare spending. Nations across the globe are allocating a substantial portion of their GDP to health-related costs, covering areas such as hospital care, physician and clinical services, other professional services, dental care, additional health services, residential and personal care, home health care, nursing care facilities, continuing care retirement communities, prescription medications, and more. Drug discovery constitutes a significant component of these health expenditures, as it is essential for treating illnesses and extending life expectancy. A growing demand exists for novel pharmaceuticals to address emerging diseases. For example, in October 2024, the Centers for Medicare and Medicaid Services, a federal agency in the United States, reported that national health expenditure rose by 4.1% to $4.5 trillion in 2022, equating to $13,493 per person. Between 2023 and 2032, the average annual growth in national health spending (5.6%) is expected to exceed the average GDP growth rate (4.3%), leading to an increase in the health spending share of GDP from 17.3% in 2022 to 19.7% in 2032. Consequently, the expansion of healthcare expenditures is fueling growth in the drug discovery market.

Drug Discovery Market Segmentation And Category Breakdown

The drug discovery market covered in this report is segmented –

1) By Drug Type: Small Molecule, Large Molecule

2) By Process: Target Selection, Target Validation, Hit-To-Lead Identification, Lead Optimization, Candidate Validation

3) By Technology: High Throughput Screening, Spectroscopy, Combinatorial Chemistry, Biochips, Pharmacogenomics And Pharmacogenetics, Bioinformatics, Metabolomics, Nanotechnology, Other Technologies

4) By Therapeutic Area: Oncology, Neurology, Infectious And Immune System Diseases, Digestive System Diseases, Cardiovascular Diseases, Diabetes, Respiratory Disease, Other Therapeutic Areas

5) By End User: Pharmaceutical Companies, CROs, Other End-Users

Subsegments:

1) By Small Molecule: Synthetic Small Molecules, Natural Small Molecules, Targeted Small Molecule Drugs

2) By Large Molecule: Monoclonal Antibodies, Proteins And Peptides, Nucleic Acid-Based Therapies

Drug Discovery Market Trends: What Is Shaping Future Industry Growth?

Key players in the drug discovery sector are introducing a range of innovative technologies—including artificial intelligence and imaging methods—with the aim of shortening the timeline needed for medication development. Through imaging technology, non-invasive visualization, characterization, and quantification of biological processes triggered by drugs inside living organisms becomes possible. Such techniques, which harness the capabilities of probes or the body’s own tissues, play a vital role in comprehending diseases and identifying novel therapeutic options. A case in point is May 2023, when Google Cloud unveiled two new AI-based platforms: the Target and Lead Identification Suite and the Multiomics Suite. These are intended to speed up drug discovery and enhance precision medicine. Specifically, the Target and Lead Identification Suite helps determine the roles of amino acids and proteins, whereas the Multiomics Suite expedites genetic data analysis and interpretation, thereby supporting the creation of more targeted treatments.

Drug Discovery Market Competitive Analysis Of Major Industry Participants

Major companies operating in the drug discovery market are Pfizer Inc., Merck & Co. Inc., Novartis International AG, Thermo Fisher Scientific Inc., WuXi AppTec Group, GlaxoSmithKline plc, Eli Lilly and Company, Laboratory Corporation of America Holdings, Evotec SE, Eurofins Scientific SE, Agilent Technologies Inc., Sanofi S.A., Charles River Laboratories International Inc., Pharmaron Ltd., Viva Biotech Ltd., Albany Molecular Research Inc., Schrödinger Inc., BioDuro Ltd., Aptuit LLC, Selvita S.A., Sygnature Discovery Limited, Jubilant Biosys Limited, Gero Limited, Domainex Ltd., Verge Genomics lnc., Aqemia SAS, BenevolentAI Limited, EPIVAX INC., ProteinQure lnc., Synlogic Inc., ChemPartner Co. Ltd., WuXi Biologics lnc., Abzena plc, Lonza Group Ltd., Catalent lnc., Recursion Pharmaceuticals Inc.

Access The Complete Drug Discovery Market Report:

https://www.thebusinessresearchcompany.com/report/drug-discovery-global-market-report?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=Jul_PR

Drug Discovery Market Regional Analysis: Which Region Leads By Revenue?

North America was the largest region in the drug discovery market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the drug discovery market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Large Will The Drug Discovery Market Be By 2030 Compared To Its 2026 Market Size?

The drug discovery market size has expanded considerably in recent years. It is anticipated to grow from $124.11 billion in 2025 to $142.54 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 14.8%. The increase observed in the past can be attributed to several factors, including a rise in chronic and infectious diseases, advancements in molecular biology techniques, increased R&D spending by pharmaceutical companies, growth in biotechnology collaborations, and the availability of research funding.

The drug discovery market is expected to witness significant expansion in the foreseeable future, with its size projected to reach $250.51 billion by 2030, reflecting a compound annual growth rate (CAGR) of 15.1%. This growth during the forecast period can be attributed to factors such as the rise of AI-driven drug discovery platforms, the increasing adoption of personalized medicine, the integration of omics data in drug design, the growth in biopharmaceutical outsourcing, and the widespread use of automation and robotics in laboratories. Key trends anticipated during this period include advancements in high-throughput screening, the development of targeted drugs, the expansion of personalized medicine approaches, the integration of pharmacogenomics, and the application of nanotechnology in drug discovery.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7746&type=smp

What Significant Factors Are Influencing The Drug Discovery Market Expansion?

The drug discovery market is anticipated to expand due to increasing healthcare expenditure. Globally, nations allocate a substantial portion of their GDP to healthcare costs, encompassing areas such as hospital care, physician and clinical services, other professional services, dental services, other health, residential, and personal care, home health care, nursing care facilities, and continuing care retirement communities, alongside prescription drugs, among others. Drug discovery constitutes a considerable component of this health spending, given its necessity for treating illnesses and extending lifespan. There is a growing demand for novel drugs to address emerging diseases. For example, reports from October 2024 by the Centers for Medicare and Medicaid Services, a US federal agency, indicated that national health expenditure expanded by 4.1% to $4.5 trillion in 2022, amounting to $13,493 per person. Furthermore, from 2023–32, the average national health expenditure growth (5.6%) is projected to exceed the average GDP growth (4.3%), leading to an increase in health spending’s share of GDP from 17.3 percent in 2022 to 19.7 percent in 2032. Consequently, the escalation in healthcare expenditures is fueling the expansion of the drug discovery market.

How Is The Drug Discovery Market Broken Down By Segment Categories?

The drug discovery market covered in this report is segmented –

1) By Drug Type: Small Molecule, Large Molecule

2) By Process: Target Selection, Target Validation, Hit-To-Lead Identification, Lead Optimization, Candidate Validation

3) By Technology: High Throughput Screening, Spectroscopy, Combinatorial Chemistry, Biochips, Pharmacogenomics And Pharmacogenetics, Bioinformatics, Metabolomics, Nanotechnology, Other Technologies

4) By Therapeutic Area: Oncology, Neurology, Infectious And Immune System Diseases, Digestive System Diseases, Cardiovascular Diseases, Diabetes, Respiratory Disease, Other Therapeutic Areas

5) By End User: Pharmaceutical Companies, CROs, Other End-Users

Subsegments:

1) By Small Molecule: Synthetic Small Molecules, Natural Small Molecules, Targeted Small Molecule Drugs

2) By Large Molecule: Monoclonal Antibodies, Proteins And Peptides, Nucleic Acid-Based Therapies

What Emerging Trends Are Seen In The Drug Discovery Market?

Leading companies in the drug discovery market are implementing various new technologies, such as AI, imaging technology, and other innovations, to decrease the time required for drug discovery. Imaging technology allows for the visualization, characterization, and quantification of non-invasive biological activities occurring within organisms in response to medications. These techniques, which utilize the strengths of either specific probes or the tissue itself, are essential for understanding diseases and discovering new treatments. For example, in May 2023, Google Cloud recently introduced two new AI-powered tools, the Target and Lead Identification Suite and the Multiomics Suite, to accelerate advancements in drug discovery and precision medicine. These tools are developed to support biotech and pharmaceutical companies in their progress within drug discovery and personalized medicine. The Target and Lead Identification Suite helps in pinpointing the function of amino acids and proteins, while the Multiomics Suite expedites the discovery and interpretation of genomic data, thereby assisting in the formulation of precision treatments.

Which Players Are Present In The Drug Discovery Market Space?

Major companies operating in the drug discovery market are Pfizer Inc., Merck & Co. Inc., Novartis International AG, Thermo Fisher Scientific Inc., WuXi AppTec Group, GlaxoSmithKline plc, Eli Lilly and Company, Laboratory Corporation of America Holdings, Evotec SE, Eurofins Scientific SE, Agilent Technologies Inc., Sanofi S.A., Charles River Laboratories International Inc., Pharmaron Ltd., Viva Biotech Ltd., Albany Molecular Research Inc., Schrödinger Inc., BioDuro Ltd., Aptuit LLC, Selvita S.A., Sygnature Discovery Limited, Jubilant Biosys Limited, Gero Limited, Domainex Ltd., Verge Genomics lnc., Aqemia SAS, BenevolentAI Limited, EPIVAX INC., ProteinQure lnc., Synlogic Inc., ChemPartner Co. Ltd., WuXi Biologics lnc., Abzena plc, Lonza Group Ltd., Catalent lnc., Recursion Pharmaceuticals Inc.

Get The Full Drug Discovery Market Report:

https://www.thebusinessresearchcompany.com/report/drug-discovery-global-market-report

Which Region Has The Greatest Market Share In The Drug Discovery Market?

North America was the largest region in the drug discovery market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the drug discovery market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Drug Discovery Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/drug-discovery-global-market-report

Browse Through More Reports Similar to the Global Drug Discovery Market 2026, By The Business Research Company

Drug Discovery Market Report 2026

https://www.thebusinessresearchcompany.com/report/drug-discovery-global-market-report

Drug Discovery Technologies Market Report 2026

https://www.thebusinessresearchcompany.com/report/drug-discovery-technologies-global-market-report

Drug Discovery Services Market Report 2026

https://www.thebusinessresearchcompany.com/report/drug-discovery-services-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Size Expansion Is Predicted For The Drug Discovery Market Between 2026 And 2030?

The drug discovery market has seen significant expansion in recent years. This market is expected to increase from $124.11 billion in 2025 to $142.54 billion in 2026, achieving a compound annual growth rate (CAGR) of 14.8%. Historically, this growth can be attributed to an uptick in chronic and infectious diseases, advancements in molecular biology techniques, increased research and development spending by pharmaceutical companies, a rise in biotechnology collaborations, and the accessibility of research funding.

The drug discovery market is projected to experience substantial growth in the upcoming years. This market is forecast to reach $250.51 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 15.1%. This expansion over the forecast period is driven by factors such as the rise of AI-powered drug discovery platforms, the increasing scope of personalized medicine, the incorporation of omics data into drug design, the growth in biopharmaceutical outsourcing, and the widespread use of automation and robotics within laboratory settings. Noteworthy trends anticipated during this period include advancements in high-throughput screening, the evolution of targeted drug development, refined personalized medicine approaches, the integration of pharmacogenomics, and nanotechnology-enabled drug discovery.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7746&type=smp

What Key Drivers Are Influencing The Growth Of The Drug Discovery Market?

The future expansion of the drug discovery market is anticipated to be fueled by increasing healthcare spending. Globally, nations allocate a significant portion of their Gross Domestic Product to various healthcare costs, encompassing hospital services, doctor and clinical visits, other specialized services, dental treatments, additional health, residential, and personal care, at-home health assistance, long-term nursing facilities, continuing care retirement communities, prescription medications, among other expenditures. Drug discovery constitutes a substantial component of health expenditure because it is essential for disease treatment and life extension. The demand for novel drugs to combat emerging diseases is growing. For example, in October 2024, the Centers for Medicare and Medicaid Services, a US-based federal agency, reported that national health expenditure expanded by 4.1% to reach $4.5 trillion in 2022, amounting to $13,493 per person. Furthermore, from 2023–32, the average national health expenditure growth (5.6%) is forecasted to exceed the average GDP growth (4.3%), leading to an increase in health spending’s share of GDP from 17.3 percent in 2022 to 19.7 percent in 2032. Consequently, the escalation in healthcare spending is driving the expansion of the drug discovery market.

Which Market Segments Are Examined In The Drug Discovery Market Study?

The drug discovery market covered in this report is segmented –

1) By Drug Type: Small Molecule, Large Molecule

2) By Process: Target Selection, Target Validation, Hit-To-Lead Identification, Lead Optimization, Candidate Validation

3) By Technology: High Throughput Screening, Spectroscopy, Combinatorial Chemistry, Biochips, Pharmacogenomics And Pharmacogenetics, Bioinformatics, Metabolomics, Nanotechnology, Other Technologies

4) By Therapeutic Area: Oncology, Neurology, Infectious And Immune System Diseases, Digestive System Diseases, Cardiovascular Diseases, Diabetes, Respiratory Disease, Other Therapeutic Areas

5) By End User: Pharmaceutical Companies, CROs, Other End-Users

Subsegments:

1) By Small Molecule: Synthetic Small Molecules, Natural Small Molecules, Targeted Small Molecule Drugs

2) By Large Molecule: Monoclonal Antibodies, Proteins And Peptides, Nucleic Acid-Based Therapies

Which Trends Are Influencing The Drug Discovery Market?

Leading companies in the drug discovery market are developing various new technologies, such as AI, imaging technology, and others, to decrease the time required for drug discovery. Imaging technology allows for the non-invasive visualization, characterization, and quantification of biological activities occurring within organisms in response to medications. These methods, which utilize the strengths of either probes or the tissue itself, are essential for understanding diseases and discovering new treatments. For instance, in May 2023, Google Cloud recently introduced two new AI-powered tools, the Target and Lead Identification Suite and the Multiomics Suite, aimed at accelerating drug discovery and precision medicine. These tools are built to help biotech and pharmaceutical companies advance drug discovery and precision medicine. The Target and Lead Identification Suite supports the identification of amino acid and protein functions, while the Multiomics Suite speeds up the discovery and interpretation of genomic data, assisting in the design of precision treatments.

Who Are The Primary Competitors In The Drug Discovery Market?

Major companies operating in the drug discovery market are Pfizer Inc., Merck & Co. Inc., Novartis International AG, Thermo Fisher Scientific Inc., WuXi AppTec Group, GlaxoSmithKline plc, Eli Lilly and Company, Laboratory Corporation of America Holdings, Evotec SE, Eurofins Scientific SE, Agilent Technologies Inc., Sanofi S.A., Charles River Laboratories International Inc., Pharmaron Ltd., Viva Biotech Ltd., Albany Molecular Research Inc., Schrödinger Inc., BioDuro Ltd., Aptuit LLC, Selvita S.A., Sygnature Discovery Limited, Jubilant Biosys Limited, Gero Limited, Domainex Ltd., Verge Genomics lnc., Aqemia SAS, BenevolentAI Limited, EPIVAX INC., ProteinQure lnc., Synlogic Inc., ChemPartner Co. Ltd., WuXi Biologics lnc., Abzena plc, Lonza Group Ltd., Catalent lnc., Recursion Pharmaceuticals Inc.

Read the full drug discovery market report here:

https://www.thebusinessresearchcompany.com/report/drug-discovery-global-market-report

Which Region Is Expected To Register The Fastest Growth In The Drug Discovery Market?

North America was the largest region in the drug discovery market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the drug discovery market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Drug Discovery Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=7746&type=smp

Browse Through More Reports Similar to the Global Drug Discovery Market 2026, By The Business Research Company

Drug Discovery Market Report 2026

https://www.thebusinessresearchcompany.com/report/drug-discovery-global-market-report

Drug Discovery Technologies Market Report 2026

https://www.thebusinessresearchcompany.com/report/drug-discovery-technologies-global-market-report

Drug Discovery Services Market Report 2026

https://www.thebusinessresearchcompany.com/report/drug-discovery-services-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Size Expansion Is Predicted For The Drug Discovery Market Between 2026 And 2030?

The drug discovery market has seen significant expansion in recent years. This market is expected to increase from $124.11 billion in 2025 to $142.54 billion in 2026, achieving a compound annual growth rate (CAGR) of 14.8%. Historically, this growth can be attributed to an uptick in chronic and infectious diseases, advancements in molecular biology techniques, increased research and development spending by pharmaceutical companies, a rise in biotechnology collaborations, and the accessibility of research funding.

The drug discovery market is projected to experience substantial growth in the upcoming years. This market is forecast to reach $250.51 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 15.1%. This expansion over the forecast period is driven by factors such as the rise of AI-powered drug discovery platforms, the increasing scope of personalized medicine, the incorporation of omics data into drug design, the growth in biopharmaceutical outsourcing, and the widespread use of automation and robotics within laboratory settings. Noteworthy trends anticipated during this period include advancements in high-throughput screening, the evolution of targeted drug development, refined personalized medicine approaches, the integration of pharmacogenomics, and nanotechnology-enabled drug discovery.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7746&type=smp

What Key Drivers Are Influencing The Growth Of The Drug Discovery Market?

The future expansion of the drug discovery market is anticipated to be fueled by increasing healthcare spending. Globally, nations allocate a significant portion of their Gross Domestic Product to various healthcare costs, encompassing hospital services, doctor and clinical visits, other specialized services, dental treatments, additional health, residential, and personal care, at-home health assistance, long-term nursing facilities, continuing care retirement communities, prescription medications, among other expenditures. Drug discovery constitutes a substantial component of health expenditure because it is essential for disease treatment and life extension. The demand for novel drugs to combat emerging diseases is growing. For example, in October 2024, the Centers for Medicare and Medicaid Services, a US-based federal agency, reported that national health expenditure expanded by 4.1% to reach $4.5 trillion in 2022, amounting to $13,493 per person. Furthermore, from 2023–32, the average national health expenditure growth (5.6%) is forecasted to exceed the average GDP growth (4.3%), leading to an increase in health spending’s share of GDP from 17.3 percent in 2022 to 19.7 percent in 2032. Consequently, the escalation in healthcare spending is driving the expansion of the drug discovery market.

Which Market Segments Are Examined In The Drug Discovery Market Study?

The drug discovery market covered in this report is segmented –

1) By Drug Type: Small Molecule, Large Molecule

2) By Process: Target Selection, Target Validation, Hit-To-Lead Identification, Lead Optimization, Candidate Validation

3) By Technology: High Throughput Screening, Spectroscopy, Combinatorial Chemistry, Biochips, Pharmacogenomics And Pharmacogenetics, Bioinformatics, Metabolomics, Nanotechnology, Other Technologies

4) By Therapeutic Area: Oncology, Neurology, Infectious And Immune System Diseases, Digestive System Diseases, Cardiovascular Diseases, Diabetes, Respiratory Disease, Other Therapeutic Areas

5) By End User: Pharmaceutical Companies, CROs, Other End-Users

Subsegments:

1) By Small Molecule: Synthetic Small Molecules, Natural Small Molecules, Targeted Small Molecule Drugs

2) By Large Molecule: Monoclonal Antibodies, Proteins And Peptides, Nucleic Acid-Based Therapies

Which Trends Are Influencing The Drug Discovery Market?

Leading companies in the drug discovery market are developing various new technologies, such as AI, imaging technology, and others, to decrease the time required for drug discovery. Imaging technology allows for the non-invasive visualization, characterization, and quantification of biological activities occurring within organisms in response to medications. These methods, which utilize the strengths of either probes or the tissue itself, are essential for understanding diseases and discovering new treatments. For instance, in May 2023, Google Cloud recently introduced two new AI-powered tools, the Target and Lead Identification Suite and the Multiomics Suite, aimed at accelerating drug discovery and precision medicine. These tools are built to help biotech and pharmaceutical companies advance drug discovery and precision medicine. The Target and Lead Identification Suite supports the identification of amino acid and protein functions, while the Multiomics Suite speeds up the discovery and interpretation of genomic data, assisting in the design of precision treatments.

Who Are The Primary Competitors In The Drug Discovery Market?

Major companies operating in the drug discovery market are Pfizer Inc., Merck & Co. Inc., Novartis International AG, Thermo Fisher Scientific Inc., WuXi AppTec Group, GlaxoSmithKline plc, Eli Lilly and Company, Laboratory Corporation of America Holdings, Evotec SE, Eurofins Scientific SE, Agilent Technologies Inc., Sanofi S.A., Charles River Laboratories International Inc., Pharmaron Ltd., Viva Biotech Ltd., Albany Molecular Research Inc., Schrödinger Inc., BioDuro Ltd., Aptuit LLC, Selvita S.A., Sygnature Discovery Limited, Jubilant Biosys Limited, Gero Limited, Domainex Ltd., Verge Genomics lnc., Aqemia SAS, BenevolentAI Limited, EPIVAX INC., ProteinQure lnc., Synlogic Inc., ChemPartner Co. Ltd., WuXi Biologics lnc., Abzena plc, Lonza Group Ltd., Catalent lnc., Recursion Pharmaceuticals Inc.

Read the full drug discovery market report here:

https://www.thebusinessresearchcompany.com/report/drug-discovery-global-market-report

Which Region Is Expected To Register The Fastest Growth In The Drug Discovery Market?

North America was the largest region in the drug discovery market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the drug discovery market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Drug Discovery Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=7746&type=smp

Browse Through More Reports Similar to the Global Drug Discovery Market 2026, By The Business Research Company

Drug Discovery Market Report 2026

https://www.thebusinessresearchcompany.com/report/drug-discovery-global-market-report

Drug Discovery Technologies Market Report 2026

https://www.thebusinessresearchcompany.com/report/drug-discovery-technologies-global-market-report

Drug Discovery Services Market Report 2026

https://www.thebusinessresearchcompany.com/report/drug-discovery-services-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Size Expansion Is Predicted For The Drug Discovery Market Between 2026 And 2030?

The drug discovery market has seen significant expansion in recent years. This market is expected to increase from $124.11 billion in 2025 to $142.54 billion in 2026, achieving a compound annual growth rate (CAGR) of 14.8%. Historically, this growth can be attributed to an uptick in chronic and infectious diseases, advancements in molecular biology techniques, increased research and development spending by pharmaceutical companies, a rise in biotechnology collaborations, and the accessibility of research funding.

The drug discovery market is projected to experience substantial growth in the upcoming years. This market is forecast to reach $250.51 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 15.1%. This expansion over the forecast period is driven by factors such as the rise of AI-powered drug discovery platforms, the increasing scope of personalized medicine, the incorporation of omics data into drug design, the growth in biopharmaceutical outsourcing, and the widespread use of automation and robotics within laboratory settings. Noteworthy trends anticipated during this period include advancements in high-throughput screening, the evolution of targeted drug development, refined personalized medicine approaches, the integration of pharmacogenomics, and nanotechnology-enabled drug discovery.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7746&type=smp

What Key Drivers Are Influencing The Growth Of The Drug Discovery Market?

The future expansion of the drug discovery market is anticipated to be fueled by increasing healthcare spending. Globally, nations allocate a significant portion of their Gross Domestic Product to various healthcare costs, encompassing hospital services, doctor and clinical visits, other specialized services, dental treatments, additional health, residential, and personal care, at-home health assistance, long-term nursing facilities, continuing care retirement communities, prescription medications, among other expenditures. Drug discovery constitutes a substantial component of health expenditure because it is essential for disease treatment and life extension. The demand for novel drugs to combat emerging diseases is growing. For example, in October 2024, the Centers for Medicare and Medicaid Services, a US-based federal agency, reported that national health expenditure expanded by 4.1% to reach $4.5 trillion in 2022, amounting to $13,493 per person. Furthermore, from 2023–32, the average national health expenditure growth (5.6%) is forecasted to exceed the average GDP growth (4.3%), leading to an increase in health spending’s share of GDP from 17.3 percent in 2022 to 19.7 percent in 2032. Consequently, the escalation in healthcare spending is driving the expansion of the drug discovery market.

Which Market Segments Are Examined In The Drug Discovery Market Study?

The drug discovery market covered in this report is segmented –

1) By Drug Type: Small Molecule, Large Molecule

2) By Process: Target Selection, Target Validation, Hit-To-Lead Identification, Lead Optimization, Candidate Validation

3) By Technology: High Throughput Screening, Spectroscopy, Combinatorial Chemistry, Biochips, Pharmacogenomics And Pharmacogenetics, Bioinformatics, Metabolomics, Nanotechnology, Other Technologies

4) By Therapeutic Area: Oncology, Neurology, Infectious And Immune System Diseases, Digestive System Diseases, Cardiovascular Diseases, Diabetes, Respiratory Disease, Other Therapeutic Areas

5) By End User: Pharmaceutical Companies, CROs, Other End-Users

Subsegments:

1) By Small Molecule: Synthetic Small Molecules, Natural Small Molecules, Targeted Small Molecule Drugs

2) By Large Molecule: Monoclonal Antibodies, Proteins And Peptides, Nucleic Acid-Based Therapies

Which Trends Are Influencing The Drug Discovery Market?

Leading companies in the drug discovery market are developing various new technologies, such as AI, imaging technology, and others, to decrease the time required for drug discovery. Imaging technology allows for the non-invasive visualization, characterization, and quantification of biological activities occurring within organisms in response to medications. These methods, which utilize the strengths of either probes or the tissue itself, are essential for understanding diseases and discovering new treatments. For instance, in May 2023, Google Cloud recently introduced two new AI-powered tools, the Target and Lead Identification Suite and the Multiomics Suite, aimed at accelerating drug discovery and precision medicine. These tools are built to help biotech and pharmaceutical companies advance drug discovery and precision medicine. The Target and Lead Identification Suite supports the identification of amino acid and protein functions, while the Multiomics Suite speeds up the discovery and interpretation of genomic data, assisting in the design of precision treatments.

Who Are The Primary Competitors In The Drug Discovery Market?

Major companies operating in the drug discovery market are Pfizer Inc., Merck & Co. Inc., Novartis International AG, Thermo Fisher Scientific Inc., WuXi AppTec Group, GlaxoSmithKline plc, Eli Lilly and Company, Laboratory Corporation of America Holdings, Evotec SE, Eurofins Scientific SE, Agilent Technologies Inc., Sanofi S.A., Charles River Laboratories International Inc., Pharmaron Ltd., Viva Biotech Ltd., Albany Molecular Research Inc., Schrödinger Inc., BioDuro Ltd., Aptuit LLC, Selvita S.A., Sygnature Discovery Limited, Jubilant Biosys Limited, Gero Limited, Domainex Ltd., Verge Genomics lnc., Aqemia SAS, BenevolentAI Limited, EPIVAX INC., ProteinQure lnc., Synlogic Inc., ChemPartner Co. Ltd., WuXi Biologics lnc., Abzena plc, Lonza Group Ltd., Catalent lnc., Recursion Pharmaceuticals Inc.

Read the full drug discovery market report here:

https://www.thebusinessresearchcompany.com/report/drug-discovery-global-market-report

Which Region Is Expected To Register The Fastest Growth In The Drug Discovery Market?

North America was the largest region in the drug discovery market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the drug discovery market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Drug Discovery Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=7746&type=smp

Browse Through More Reports Similar to the Global Drug Discovery Market 2026, By The Business Research Company

Drug Discovery Market Report 2026

https://www.thebusinessresearchcompany.com/report/drug-discovery-global-market-report

Drug Discovery Technologies Market Report 2026

https://www.thebusinessresearchcompany.com/report/drug-discovery-technologies-global-market-report

Drug Discovery Services Market Report 2026

https://www.thebusinessresearchcompany.com/report/drug-discovery-services-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the drug discovery market from 2026–2035 with trusted insights from The Business Research Company

What market expansion outlook does the Drug Discovery Market show for the 2026–2030 period?

The drug discovery market has experienced substantial expansion recently. Its valuation is projected to increase from $124.11 billion in 2025 to $142.54 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 14.8%. Factors contributing to its historical growth include an uptick in chronic and infectious diseases, progress in molecular biology techniques, increased research and development expenditure by pharmaceutical firms, an expansion in biotechnology partnerships, and the provision of research funding.

The drug discovery market is projected to undergo substantial growth in the upcoming years. Its valuation is expected to reach $250.51 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 15.1%. This projected expansion is driven by the emergence of AI-driven drug discovery platforms, the broadening scope of personalized medicine, the integration of omics data in drug design, the increase in biopharmaceutical outsourcing activities, and the implementation of automation and robotics within laboratories. Noteworthy trends anticipated during this period include advancements in high-throughput screening, the progression of targeted drug development, the adoption of personalized medicine approaches, the incorporation of pharmacogenomics, and nanotechnology-enabled drug discovery methods.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7746&type=smp

What Drivers Are Shaping The Development Of The Drug Discovery Market?

The drug discovery market is anticipated to expand due to increasing healthcare expenditure. Countries across the globe allocate a substantial portion of their GDP to healthcare costs, covering hospital care, physician and clinical services, other professional services, dental services, other health, residential, and personal care, home health care, nursing care facilities, and continuing care retirement communities, alongside prescription drugs, among other categories. Drug discovery constitutes a crucial element of health expenditure, as it is essential for treating diseases and prolonging life. There is a growing demand for novel medications to address emerging diseases. For instance, in October 2024, according to the Centers for Medicare and Medicaid Services, a US-based federal agency, national health expenditure increased 4.1% to $4.5 trillion in 2022, or $13,493 per person. Over the period of 2023–32, the average national health expenditure growth (5.6%) is projected to surpass that of average GDP growth (4.3%), leading to an increase in the health spending share of GDP from 17.3 percent in 2022 to 19.7 percent in 2032. Therefore, the escalation in healthcare expenditures is fueling the growth of the drug discovery market.

Which Segments Are Contributing To The Growth Of The Drug Discovery Market?

The drug discovery market covered in this report is segmented –

1) By Drug Type: Small Molecule, Large Molecule

2) By Process: Target Selection, Target Validation, Hit-To-Lead Identification, Lead Optimization, Candidate Validation

3) By Technology: High Throughput Screening, Spectroscopy, Combinatorial Chemistry, Biochips, Pharmacogenomics And Pharmacogenetics, Bioinformatics, Metabolomics, Nanotechnology, Other Technologies

4) By Therapeutic Area: Oncology, Neurology, Infectious And Immune System Diseases, Digestive System Diseases, Cardiovascular Diseases, Diabetes, Respiratory Disease, Other Therapeutic Areas

5) By End User: Pharmaceutical Companies, CROs, Other End-Users

Subsegments:

1) By Small Molecule: Synthetic Small Molecules, Natural Small Molecules, Targeted Small Molecule Drugs

2) By Large Molecule: Monoclonal Antibodies, Proteins And Peptides, Nucleic Acid-Based Therapies

What Trends Are Reshaping The Dynamics Of The Drug Discovery Market?

Major companies operating in the drug discovery market are implementing various new technologies, including AI and imaging, to decrease the time required for drug development. Imaging technology specifically allows for the non-invasive visualization, characterization, and quantification of biological activities occurring within organisms in response to medications. These methods, which harness the strengths of either probes or the tissue itself, are crucial for gaining insights into diseases and identifying new therapeutic approaches. For instance, in May 2023, Google Cloud launched two new AI-powered tools, the Target and Lead Identification Suite and the Multiomics Suite, with the goal of accelerating drug discovery and precision medicine. These tools are designed to assist biotech and pharmaceutical companies in advancing drug discovery and precision medicine efforts. The Target and Lead Identification Suite helps in identifying the function of amino acids and proteins, while the Multiomics Suite speeds up the discovery and interpretation of genomic data, thereby aiding in the design of precision treatments.

Who Are The Primary Competitors In The Global Drug Discovery Market?

Major companies operating in the drug discovery market are Pfizer Inc., Merck & Co. Inc., Novartis International AG, Thermo Fisher Scientific Inc., WuXi AppTec Group, GlaxoSmithKline plc, Eli Lilly and Company, Laboratory Corporation of America Holdings, Evotec SE, Eurofins Scientific SE, Agilent Technologies Inc., Sanofi S.A., Charles River Laboratories International Inc., Pharmaron Ltd., Viva Biotech Ltd., Albany Molecular Research Inc., Schrödinger Inc., BioDuro Ltd., Aptuit LLC, Selvita S.A., Sygnature Discovery Limited, Jubilant Biosys Limited, Gero Limited, Domainex Ltd., Verge Genomics lnc., Aqemia SAS, BenevolentAI Limited, EPIVAX INC., ProteinQure lnc., Synlogic Inc., ChemPartner Co. Ltd., WuXi Biologics lnc., Abzena plc, Lonza Group Ltd., Catalent lnc., Recursion Pharmaceuticals Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/drug-discovery-global-market-report

Which Global Regions Are Shaping The Competitive Landscape Of The Drug Discovery Market?

North America was the largest region in the drug discovery market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the drug discovery market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Drug Discovery Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=7746&type=smp

Browse Through More Reports Similar to the Global Drug Discovery Market 2026, By The Business Research Company

Drug Discovery Market Report 2026

https://www.thebusinessresearchcompany.com/report/drug-discovery-global-market-report

Drug Discovery Technologies Market Report 2026

https://www.thebusinessresearchcompany.com/report/drug-discovery-technologies-global-market-report

Drug Discovery Services Market Report 2026

https://www.thebusinessresearchcompany.com/report/drug-discovery-services-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the drug discovery market from 2025–2034 with trusted insights from The Business Research Company

What Is The Present Size Of The Drug Discovery Market And What Value Is Projected For 2029?

The drug discovery market has experienced substantial growth in recent years. Its size is predicted to increase from $110.26 billion in 2024 to $124.11 billion in 2025, achieving a compound annual growth rate (CAGR) of 12.6%. This past growth can be attributed to various factors such as advancements in genomics and proteomics, the expanding prevalence of chronic diseases, and the emergence of biopharmaceuticals.

The drug discovery market is projected to experience substantial growth in the coming years, with its size expected to reach $217.01 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 15.0%. This expansion during the forecast period is primarily driven by the increasing adoption of precision medicine, a stronger focus on rare diseases, and the broader availability of personalized therapies. Key trends anticipated in this period include the development of collaborative drug discovery models, continued emphasis on rare diseases and orphan drugs, the integration of multi-omics data, the rapid uptake of organoids and 3D cell culture models, and ongoing advancements in virtual screening techniques.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7746&type=smp

What Factors Are Boosting The Drug Discovery Market?

Increased healthcare spending is anticipated to drive the drug discovery market. Countries worldwide dedicate a substantial share of their GDP to healthcare expenses, which include hospital care, physician and clinical services, dental services, various other health, residential, and personal care, home health care, nursing care facilities, continuing care retirement communities, and prescription drugs. Drug discovery represents a significant portion of health expenditure, as it is crucial for treating diseases and extending life, with an escalating demand for new drugs to address novel diseases. For instance, in October 2024, the Centers for Medicare and Medicaid Services, a US-based federal agency, reported that national health expenditure grew 4.1% to $4.5 trillion in 2022, or $13,493 per person. Projections for 2023–32 indicate that the average national health expenditure growth (5.6%) is expected to exceed average GDP growth (4.3%), leading to an increase in health spending as a share of GDP from 17.3 percent in 2022 to 19.7 percent in 2032. Therefore, the rise in healthcare expenditures is a key driver for the growth of the drug discovery market.

What Are The Core Segmentation Criteria In The Drug Discovery Market?

The drug discovery market covered in this report is segmented –

1) By Drug Type: Small Molecule, Large Molecule

2) By Process: Target Selection, Target Validation, Hit-To-Lead Identification, Lead Optimization, Candidate Validation

3) By Technology: High Throughput Screening, Spectroscopy, Combinatorial Chemistry, Biochips, Pharmacogenomics And Pharmacogenetics, Bioinformatics, Metabolomics, Nanotechnology, Other Technologies

4) By Therapeutic Area: Oncology, Neurology, Infectious And Immune System Diseases, Digestive System Diseases, Cardiovascular Diseases, Diabetes, Respiratory Disease, Other Therapeutic Areas

5) By End User: Pharmaceutical Companies, CROs, Other End-Users

Subsegments:

1) By Small Molecule: Synthetic Small Molecules, Natural Small Molecules, Targeted Small Molecule Drugs

2) By Large Molecule: Monoclonal Antibodies, Proteins And Peptides, Nucleic Acid-Based Therapies

Which Emerging Trends Are Reshaping The Drug Discovery Market Landscape?

Technological advancements represent a significant trend within the drug discovery market. Companies active in the drug discovery market are introducing various new technologies, including AI, imaging technology, and others, with the goal of reducing the time needed for drug discovery. Imaging technology enables the non-invasive visualization, characterization, and quantification of biological activities occurring inside organisms in response to medications. These methodologies, which leverage the strengths of either probes or the tissue itself, are vital for understanding diseases and developing new treatments. For instance, in May 2023, Google Cloud recently launched two novel AI-powered tools, the Target and Lead Identification Suite and the Multiomics Suite, to expedite drug discovery and precision medicine. These tools are engineered to assist biotech and pharmaceutical companies in advancing drug discovery and precision medicine. The Target and Lead Identification Suite aids in identifying the function of amino acids and proteins, while the Multiomics Suite accelerates the discovery and interpretation of genomic data, thereby supporting the design of precision treatments.

Which Players Are Shaping The Competitive Landscape Of The Drug DiscoveryXX Market?

Major companies operating in the drug discovery market include Pfizer Inc., Merck & Co. Inc., Novartis International AG, Thermo Fisher Scientific Inc., WuXi AppTec Group, GlaxoSmithKline plc, Eli Lilly and Company, Laboratory Corporation of America Holdings, Evotec SE, Eurofins Scientific SE, Agilent Technologies Inc., Sanofi S.A., Charles River Laboratories International Inc., Pharmaron Ltd., Viva Biotech Ltd., Albany Molecular Research Inc., Schrödinger Inc., BioDuro Ltd., Aptuit LLC, Selvita S.A., Sygnature Discovery Limited, Jubilant Biosys Limited, Gero Limited, Domainex Ltd., Verge Genomics lnc., Aqemia SAS, BenevolentAI Limited, EPIVAX INC., ProteinQure lnc., Synlogic Inc., ChemPartner Co. Ltd., WuXi Biologics lnc., Abzena plc, Lonza Group Ltd., Catalent lnc., Recursion Pharmaceuticals Inc.

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/drug-discovery-global-market-report

What Regional Trends Are Shaping Growth In The Drug Discovery Market?

North America was the largest region in the drug discovery market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the drug discovery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=7746&type=smp

Browse Through More Reports Similar to the Global Drug Discovery Market 2025, By The Business Research Company

3D Cell Culture Technologies Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/3d-cell-culture-technologies-global-market-report

Cell Based Assays Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cell-based-assays-global-market-report

Laboratory Automation Systems Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/laboratory-automation-systems-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Anticipated Size Of The Drug Discovery Market Over The Five-Year Period 2025–2029?

The drug discovery market size has seen substantial growth recently. It is forecast to expand from $110.26 billion in 2024 to $124.11 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 12.6%. This historical expansion can be attributed to advancements in genomics and proteomics, the increasing prevalence of chronic diseases, and the emergence of biopharmaceuticals.

The drug discovery market size is projected to experience rapid growth in the upcoming years, expanding to $217.01 billion by 2029, with a compound annual growth rate (CAGR) of 15.0%. This expansion during the forecast period is attributed to factors like the adoption of precision medicine, a heightened focus on rare diseases, and the proliferation of personalized therapies. Key trends expected over the forecast period include collaborative drug discovery models, a strong emphasis on rare diseases and orphan drugs, the integration of multi-omics data, the swift adoption of organoids and 3D cell culture models, and advancements in virtual screening methods.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7746&type=smp

What Are The Main Drivers Boosting The Drug Discovery Industry’s Expansion?

The drug discovery market is expected to be invigorated by increasing healthcare spending in the coming years. Globally, countries dedicate a substantial portion of their GDP to various healthcare costs, which encompass hospital care, physician and clinical services, other professional services, dental services, other health, residential, and personal care, home health care, nursing care facilities, and continuing care retirement communities, alongside prescription drugs, and other related expenses. Drug discovery represents a significant segment of this health expenditure, as it is essential for treating diseases and extending human life. There is a growing demand for novel pharmaceutical agents to address new illnesses. For instance, in October 2024, data from the Centers for Medicare and Medicaid Services, a federal agency based in the US, indicated that national health expenditure expanded by 4.1% to reach $4.5 trillion in 2022, or $13,493 per person. Furthermore, for the period 2023–32, the average national health expenditure growth (5.6%) is projected to surpass the average GDP growth (4.3%), which will lead to an increase in health spending’s share of GDP from 17.3 percent in 2022 to 19.7 percent in 2032. Consequently, this escalation in healthcare expenditures is a key factor driving the expansion of the drug discovery market.

What Are The Emerging Segments Gaining Attention In The Drug Discovery Market?

The drug discovery market covered in this report is segmented –

1) By Drug Type: Small Molecule, Large Molecule

2) By Process: Target Selection, Target Validation, Hit-To-Lead Identification, Lead Optimization, Candidate Validation

3) By Technology: High Throughput Screening, Spectroscopy, Combinatorial Chemistry, Biochips, Pharmacogenomics And Pharmacogenetics, Bioinformatics, Metabolomics, Nanotechnology, Other Technologies

4) By Therapeutic Area: Oncology, Neurology, Infectious And Immune System Diseases, Digestive System Diseases, Cardiovascular Diseases, Diabetes, Respiratory Disease, Other Therapeutic Areas

5) By End User: Pharmaceutical Companies, CROs, Other End-Users

Subsegments:

1) By Small Molecule: Synthetic Small Molecules, Natural Small Molecules, Targeted Small Molecule Drugs

2) By Large Molecule: Monoclonal Antibodies, Proteins And Peptides, Nucleic Acid-Based Therapies

How Are Trends Influencing The Drug Discovery Market?

Significant progress in technology represents a primary trend within the drug discovery market. Firms engaged in the drug discovery market are introducing diverse novel technologies, including AI and imaging technology, among others, with the aim of shortening the drug discovery timeline. Imaging technology facilitates the non-intrusive visualization, characterization, and quantification of biological processes happening inside organisms in reaction to drugs. These approaches, leveraging the advantages of either probes or the tissue itself, are vital for comprehending illnesses and identifying novel therapeutic options. For example, in May 2023, Google Cloud unveiled two innovative AI-driven tools, the Target and Lead Identification Suite and the Multiomics Suite, designed to speed up drug discovery and advance precision medicine. The purpose of these tools is to assist biotechnology and pharmaceutical enterprises in furthering drug discovery and precision medicine efforts. The Target and Lead Identification Suite supports the identification of amino acid and protein functions, whereas the Multiomics Suite hastens the discovery and understanding of genomic data, thereby contributing to the development of tailored treatments.

Who Are The Major Companies Operating In The Drug Discovery Market?

Major companies operating in the drug discovery market include Pfizer Inc., Merck & Co. Inc., Novartis International AG, Thermo Fisher Scientific Inc., WuXi AppTec Group, GlaxoSmithKline plc, Eli Lilly and Company, Laboratory Corporation of America Holdings, Evotec SE, Eurofins Scientific SE, Agilent Technologies Inc., Sanofi S.A., Charles River Laboratories International Inc., Pharmaron Ltd., Viva Biotech Ltd., Albany Molecular Research Inc., Schrödinger Inc., BioDuro Ltd., Aptuit LLC, Selvita S.A., Sygnature Discovery Limited, Jubilant Biosys Limited, Gero Limited, Domainex Ltd., Verge Genomics lnc., Aqemia SAS, BenevolentAI Limited, EPIVAX INC., ProteinQure lnc., Synlogic Inc., ChemPartner Co. Ltd., WuXi Biologics lnc., Abzena plc, Lonza Group Ltd., Catalent lnc., Recursion Pharmaceuticals Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/drug-discovery-global-market-report

Which Geographies Are Emerging As Strong Markets For The Drug Discovery Industry?

North America was the largest region in the drug discovery market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the drug discovery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Drug Discovery Market Report:

https://www.thebusinessresearchcompany.com/customise?id=7746&type=smp

Browse Through More Reports Similar to the Global Drug Discovery Market 2025, By The Business Research Company

3D Cell Culture Technologies Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/3d-cell-culture-technologies-global-market-report

Cell Based Assays Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cell-based-assays-global-market-report

Laboratory Automation Systems Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/laboratory-automation-systems-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model